Kurt Gustafson
Förmögenhet: 1 M $ per 2026-06-30
Förmögenhet: 1 M $ per 2026-06-30
Kurt A. Gustafson is currently Independent Director at Xencor, Inc. since 2014.
Mr. Gustafson is Chief Financial Officer & Executive VP-Finance at OmniAb Operations, Inc. and OmniAb, Inc., both positions starting in 2022.
Formerly, Mr. Gustafson was Independent Non-Executive Director at Niagen Bioscience, Inc. from 2016 to 2022.
Mr. Gustafson was Chief Financial Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2013 to 2022.
Mr. Gustafson was Chief Financial Officer & Vice President at Halozyme Therapeutics, Inc. from 2012 to 2013.
Mr. Gustafson was Chief Financial Officer & VP-Manufacturing Finance at Amgen, Inc. in 2009.
Mr. Gustafson was Chief Financial Officer & Vice President-Finance at Amgen Europe BV from 2004 to 2006.
Mr. Gustafson held the roles of Chief Financial Officer, Treasurer & VP at Amgen International AG.
Mr. Gustafson worked as Staff Auditor at Horwath Velez & Co. PSC.
Education includes an MBA from the University of California, Los Angeles and an undergraduate degree from North Park University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
OMNIAB, INC. 0,18 % | 2026-04-23 | 261 483 ( 0,18 % ) | 643 248 $ | 2026-06-30 |
XENCOR, INC. 0,03 % | 2026-06-16 | 25 011 ( 0,03 % ) | 402 677 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| XENCOR, INC. | Direktör/Styrelseledamot | 2014-07-25 |
| OMNIAB, INC. | Finansdirektör/CFO | 2022-03-01 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Finansdirektör/CFO | 2022-03-01 |
| Företag | Position | Slut |
|---|---|---|
| NIAGEN BIOSCIENCE, INC. | Direktör/Styrelseledamot | 2022-06-16 |
| SPECTRUM PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2022-03-18 |
| HALOZYME THERAPEUTICS, INC. | Finansdirektör/CFO | 2013-05-20 |
| AMGEN INC. | Finansdirektör/CFO | 2009-01-01 |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Finansdirektör/CFO | 2006-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Xencor, Inc.
Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Park University
North Park University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horwath Velez & Co. PSC
Horwath Velez & Co. PSC Miscellaneous Commercial ServicesCommercial Services Horwath Velez & Co. PSC is a private company based in Washington, DC. | Commercial Services |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Chromadex Corp.
Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
Amgen International AG | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån